Post Hoc analyses of GOG 9923: Does BRCA status affect toxicities?: an NRG Oncology Study

OBJECTIVE: To evaluate how women with epithelial ovarian cancer (EOC), dichotomized by BRCA status, tolerate intravenous (IV) or intraperitoneal (IP) chemotherapy given with veliparib and bevacizumab (bev) on a GOG phase I study (GOG 9923, NCT00989651). METHODS: This is an unplanned, post hoc analys...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Gynecol Oncol
Asıl Yazarlar: Gillen, Jessica, Miller, Austin, Bell-McGuinn, Katherine M, Schilder, Russell J, Walker, Joan L, Mathews, Cara A., Duska, Linda R., Guntupalli, Saketh R, O’Cearbhaill, Roisin, Hays, John, Hagemann, Andrea R., Gray, Heidi J., Gordon, Sarah W., Armstrong, Deborah K., Chen, Alice, Fracasso, Paula M., Aghajanian, Carol, Moore, Kathleen N.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8084973/
https://ncbi.nlm.nih.gov/pubmed/33610319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2021.01.037
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller